bioRxivBiochemistryPreprint
Impaired cholesterol metabolism in the mice model of cystic fibrosis. A vicious circle?
F. Amato, A. Castaldo, G. Castaldo, G. Cernera, G. Corso, E. Ferrari, M. Gelzo, R. Monzani, V. R. Villella, V. Raia
Abstract
Patients with cystic fibrosis (CF) have low cholesterol absorption and, despite enhanced endogenous biosynthesis, low serum cholesterol. Herein, we investigated cholesterol metabolism in a murine CF model in comparison to wild type (WT) testing serum and liver surrogate biomarkers together with the hepatic expression of genes involved in cholesterol metabolism. CF mice display lower sterols absorption and increased endogenous biosynthesis. Subsequently, we evaluated the effects of a cholesterol-supplemented diet on cholesterol metabolism in CF and WT mice. The supplementation in WT mice determines biochemical changes similar to humans. Instead, CF mice with supplementation did not show significant changes, except for serum phytosterols (-50%), liver cholesterol (+35%) and TNF mRNA expression, that resulted 5-fold higher than in CF without supplementation. However, liver cholesterol in CF mice with supplementation resulted significantly lower compared to WT supplemented mice. This study shows that in CF mice there is a vicious circle in which the altered bile salts synthesis/secretion contribute to reduce cholesterol digestion/absorption. The consequence is the enhanced liver cholesterol biosynthesis that accumulates in the cell triggering inflammation.
- organism: mouse
- assay: bulk RNA-seq
- research focus: cell type annotation
- research focus: differential expression
- research focus: gene regulatory network inference
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Profiling Bile Acids in the Stools of Humans and Animal Models of Cystic Fibrosis
Melissa M. Carmichael, Rebecca A. Valls, … George A. O’Toole·Microbiology SpectrumPeer-reviewed·Sep 16, 2025
- Gut microbes mediate the synergistic effects of dietary cholesterol and saturated fat in driving fibrosing MASH
Jake B. Hermanson, Samar A. Tolba, … Vanessa Leone·Gut MicrobesPeer-reviewed·May 10, 2026
- Liver lipid droplet cholesterol content is a key determinant of metabolic dysfunction-associated steatohepatitis
Ikki Sakuma, Rafael Calais Gaspar, … Gerald I. Shulman·Proceedings of the National Academy of SciencesPeer-reviewed·May 1, 2025
- Coronary Microvascular Dysfunction is Associated with Augmented Lysosomal Signaling in Hypercholesterolemic Mice
Yunting Wang, Alexandra K. Moura, … Xiang Li·Journal of the American Heart AssociationPeer-reviewed·Nov 27, 2024
- Surf4 deficiency reduces intestinal lipid absorption and secretion and decreases metabolism in mice
G. Tao, H. Wang, … D.-w. Zhang·Arteriosclerosis, Thrombosis, and Vascular BiologyPeer-reviewed·Apr 1, 2023
- Fecal Dysbiosis and Inflammation in Intestinal-Specific Cftr Knockout Mice on Regimens Preventing Intestinal Obstruction
Sarah M. Young, Rowena A. Woode, … Lane L. Clarke·Physiological GenomicsPeer-reviewed·Dec 11, 2023